259 related articles for article (PubMed ID: 33660929)
1. Effect of mechanistic/mammalian target of rapamycin complex 1 on mitochondrial dynamics during skeletal muscle hypertrophy.
Uemichi K; Shirai T; Hanakita H; Takemasa T
Physiol Rep; 2021 Mar; 9(5):e14789. PubMed ID: 33660929
[TBL] [Abstract][Full Text] [Related]
2. The effect of caffeine on skeletal muscle anabolic signaling and hypertrophy.
Moore TM; Mortensen XM; Ashby CK; Harris AM; Kump KJ; Laird DW; Adams AJ; Bray JK; Chen T; Thomson DM
Appl Physiol Nutr Metab; 2017 Jun; 42(6):621-629. PubMed ID: 28177708
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of CaMKKα signaling is sufficient but not necessary for mTORC1 activation and growth in mouse skeletal muscle.
Ferey JL; Brault JJ; Smith CA; Witczak CA
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E686-94. PubMed ID: 25159322
[TBL] [Abstract][Full Text] [Related]
4. Extracellular transglutaminase 2 induces myotube hypertrophy through G protein-coupled receptor 56.
Kitakaze T; Yoshikawa M; Kobayashi Y; Kimura N; Goshima N; Ishikawa T; Ogata Y; Yamashita Y; Ashida H; Harada N; Yamaji R
Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118563. PubMed ID: 31666191
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle-specific knockout of DEP domain containing 5 protein increases mTORC1 signaling, muscle cell hypertrophy, and mitochondrial respiration.
Graber TG; Fry CS; Brightwell CR; Moro T; Maroto R; Bhattarai N; Porter C; Wakamiya M; Rasmussen BB
J Biol Chem; 2019 Mar; 294(11):4091-4102. PubMed ID: 30635399
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial fusion- and fission-related protein expression in the regulation of skeletal muscle mass.
Nakano D; Machida S
Physiol Rep; 2022 Apr; 10(8):e15281. PubMed ID: 35439362
[TBL] [Abstract][Full Text] [Related]
7. Transient activation of mTORC1 signaling in skeletal muscle is independent of Akt1 regulation.
Miyazaki M; Moriya N; Takemasa T
Physiol Rep; 2020 Oct; 8(19):e14599. PubMed ID: 33038070
[TBL] [Abstract][Full Text] [Related]
8. Molecular brakes regulating mTORC1 activation in skeletal muscle following synergist ablation.
Hamilton DL; Philp A; MacKenzie MG; Patton A; Towler MC; Gallagher IJ; Bodine SC; Baar K
Am J Physiol Endocrinol Metab; 2014 Aug; 307(4):E365-73. PubMed ID: 24961241
[TBL] [Abstract][Full Text] [Related]
9. Akt1 deficiency diminishes skeletal muscle hypertrophy by reducing satellite cell proliferation.
Moriya N; Miyazaki M
Am J Physiol Regul Integr Comp Physiol; 2018 May; 314(5):R741-R751. PubMed ID: 29443546
[TBL] [Abstract][Full Text] [Related]
10. The regulation of polyamine pathway proteins in models of skeletal muscle hypertrophy and atrophy: a potential role for mTORC1.
Tabbaa M; Ruz Gomez T; Campelj DG; Gregorevic P; Hayes A; Goodman CA
Am J Physiol Cell Physiol; 2021 Jun; 320(6):C987-C999. PubMed ID: 33881936
[TBL] [Abstract][Full Text] [Related]
11. The role of the mechanistic target of rapamycin complex 1 in the regulation of mitochondrial adaptation during skeletal muscle atrophy under denervation or calorie restriction in mice.
Uemichi K; Shirai T; Matsuno R; Iwata T; Tanimura R; Takemasa T
Appl Physiol Nutr Metab; 2023 Mar; 48(3):241-255. PubMed ID: 36786420
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin Ameliorates Cognitive Impairments and Alzheimer's Disease-Like Pathology with Restoring Mitochondrial Abnormality in the Hippocampus of Streptozotocin-Induced Diabetic Mice.
Ding Y; Liu H; Cen M; Tao Y; Lai C; Tang Z
Neurochem Res; 2021 Feb; 46(2):265-275. PubMed ID: 33140268
[TBL] [Abstract][Full Text] [Related]
13. Early activation of mTORC1 signalling in response to mechanical overload is independent of phosphoinositide 3-kinase/Akt signalling.
Miyazaki M; McCarthy JJ; Fedele MJ; Esser KA
J Physiol; 2011 Apr; 589(Pt 7):1831-46. PubMed ID: 21300751
[TBL] [Abstract][Full Text] [Related]
14. Raptor is critical for increasing the mitochondrial proteome and skeletal muscle force during hypertrophy.
Baraldo M; Nogara L; Dumitras GA; Tchampda Dondjang AH; Geremia A; Scalabrin M; Türk C; Telkamp F; Zentilin L; Giacca M; Krüger M; Blaauw B
FASEB J; 2021 Dec; 35(12):e22031. PubMed ID: 34767636
[TBL] [Abstract][Full Text] [Related]
15. 2,6-Dimethoxy-1,4-benzoquinone increases skeletal muscle mass and performance by regulating AKT/mTOR signaling and mitochondrial function.
Yoo A; Jang YJ; Ahn J; Jung CH; Ha TY
Phytomedicine; 2021 Oct; 91():153658. PubMed ID: 34332284
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor I-mediated skeletal muscle hypertrophy is characterized by increased mTOR-p70S6K signaling without increased Akt phosphorylation.
Song YH; Godard M; Li Y; Richmond SR; Rosenthal N; Delafontaine P
J Investig Med; 2005 Apr; 53(3):135-42. PubMed ID: 15921033
[TBL] [Abstract][Full Text] [Related]
17. The role of raptor in the mechanical load-induced regulation of mTOR signaling, protein synthesis, and skeletal muscle hypertrophy.
You JS; McNally RM; Jacobs BL; Privett RE; Gundermann DM; Lin KH; Steinert ND; Goodman CA; Hornberger TA
FASEB J; 2019 Mar; 33(3):4021-4034. PubMed ID: 30509128
[TBL] [Abstract][Full Text] [Related]
18. Eicosapentaenoic acid enhances skeletal muscle hypertrophy without altering the protein anabolic signaling pathway.
Siriguleng S; Koike T; Natsume Y; Jiang H; Mu L; Oshida Y
Physiol Res; 2021 Mar; 70(1):55-65. PubMed ID: 33453714
[TBL] [Abstract][Full Text] [Related]
19. The transcriptional coactivator PGC-1α is dispensable for chronic overload-induced skeletal muscle hypertrophy and metabolic remodeling.
Pérez-Schindler J; Summermatter S; Santos G; Zorzato F; Handschin C
Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20314-9. PubMed ID: 24277823
[TBL] [Abstract][Full Text] [Related]
20. Transforming Growth Factor β1-induced Apoptosis in Podocytes via the Extracellular Signal-regulated Kinase-Mammalian Target of Rapamycin Complex 1-NADPH Oxidase 4 Axis.
Das R; Xu S; Nguyen TT; Quan X; Choi SK; Kim SJ; Lee EY; Cha SK; Park KS
J Biol Chem; 2015 Dec; 290(52):30830-42. PubMed ID: 26565025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
